Arcutis Biotherapeutics Inc.
ARQT | NASDAQ
$25.96
+$0.58 (+2.29%)
At close: Sep 21, 2026, 4:00 PM ET
$25.96
$0 (0.00%)
Pre-market:
Sep 22, 2026, 4:00 AM ET
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 463.98M | 415.62M | 376.07M | 317.93M | 263.47M | 212.82M | 196.54M | 138.71M | 132.06M | 106.39M | 59.61M | 49.04M | 11.66M | 6.47M | 3.69M | 725K | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 41.1M | 37.65M | 36.7M | 31.91M | 28.73M | 24.7M | 19.13M | 14.47M | 10.15M | 7.46M | 4.99M | 3.23M | 2.31M | 1.77M | 1.22M | 943K | 866K | 814K | 763K | 718K | 526K | 401K |
Gross Profit | 422.89M | 377.98M | 339.38M | 286.02M | 234.74M | 188.12M | 177.41M | 124.24M | 121.91M | 98.93M | 54.62M | 45.82M | 9.34M | 4.7M | 2.47M | -218K | -866K | -814K | -763K | -718K | -526K | -401K |
Operating Income | 34.25M | 3.21M | -12.23M | -38.25M | -85.84M | -121.3M | -128.4M | -181.93M | -179.77M | -196.46M | -241.1M | -248.36M | -316.2M | -315.26M | -301.63M | -304.49M | -256.82M | -233.07M | -206.53M | -169.31M | -150.53M | -144.08M |
Interest Income | 4.55M | 2.28M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | 29.3M | -1.39M | -14.97M | -43.3M | -92.33M | -129.12M | -139.39M | -195.19M | -195.39M | -214.05M | -259.09M | -264.85M | -330.82M | -327.23M | -311.46M | -310.77M | -260.04M | -234.64M | -206.36M | -169.08M | -150.3M | -143.71M |
Net Income | 28.52M | -2.38M | -16.14M | -44.32M | -93.27M | -129.72M | -140.04M | -195.54M | -198.76M | -217.42M | -261.78M | -267.51M | -330.46M | -326.87M | -311.46M | -310.77M | -260.04M | -234.64M | -206.36M | -169.08M | -150.3M | -143.71M |
Selling & General & Admin | 297.6M | 284.63M | 274.55M | 253.18M | 249.6M | 238.6M | 229.39M | 220.46M | 209.24M | 197.02M | 185.15M | 173.49M | 161.37M | 143.04M | 122.12M | 103.83M | 84.83M | 68.52M | 60.97M | 48.93M | 38.02M | 32.32M |
Research & Development | 91.04M | 90.14M | 77.05M | 71.08M | 70.98M | 70.82M | 76.42M | 85.72M | 92.45M | 98.37M | 110.58M | 120.68M | 164.17M | 177.16M | 182.44M | 201.12M | 171.99M | 164.55M | 145.56M | 120.37M | 112.51M | 111.76M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 388.63M | 374.76M | 351.6M | 324.26M | 320.57M | 309.42M | 305.81M | 306.17M | 301.69M | 295.39M | 295.72M | 294.17M | 325.54M | 319.96M | 304.1M | 304.27M | 255.95M | 232.26M | 205.77M | 168.76M | 150.17M | 143.84M |
Interest Expense | 13.85M | 13.47M | 12.08M | 14.63M | 18.22M | 22.67M | 27.17M | 29.38M | 30.29M | 30.15M | 29.71M | 28.87M | 26.21M | 20.86M | 15.65M | 8.74M | 3.84M | 1.84M | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 429.73M | 412.41M | 388.3M | 356.18M | 349.3M | 334.12M | 324.94M | 320.64M | 311.83M | 302.85M | 300.71M | 297.4M | 327.86M | 321.73M | 305.31M | 305.21M | 256.82M | 233.07M | 206.53M | 169.31M | 150.53M | 144.08M |
Income Tax Expense | 779K | 985K | 1.17M | 1.02M | 944K | 602K | 647K | 349K | 3.37M | 3.37M | 3.05M | 3.02M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 130.52M | 129.37M | 128.25M | 127.62M | 127M | 126.04M | 120.96M | 124.3M | 123.48M | 111.05M | 92.58M | 61.73M | 61.43M | 61.17M | 60.96M | 57.09M | 51.42M | 50.51M | 50.2M | 50.1M | 50M | 47.28M |
Shares Outstanding (Diluted) | 135.9M | 129.37M | 135.64M | 132.89M | 127M | 126.04M | 120.96M | 124.3M | 123.48M | 111.05M | 92.58M | 61.73M | 61.43M | 61.17M | 60.96M | 57.09M | 51.42M | 50.51M | 50.2M | 50.1M | 50M | 47.28M |
EPS (Basic) | 0.22 | -0.02 | -0.13 | -0.36 | -0.75 | -1.04 | -1.16 | -1.79 | -2.19 | -2.93 | -3.91 | -4.43 | -5.64 | -5.82 | -5.83 | -6.01 | -5.21 | -4.71 | -4.16 | -3.53 | -3.40 | -3.50 |
EPS (Diluted) | 0.21 | -0.03 | -0.14 | -0.36 | -0.75 | -1.04 | -1.16 | -1.79 | -2.19 | -2.93 | -3.91 | -4.43 | -5.64 | -5.82 | -5.83 | -6.01 | -5.21 | -4.71 | -4.16 | -3.53 | -3.40 | -3.50 |
EBITDA | 44.13M | 15.03M | 2.63M | -23.95M | -68.53M | -101.07M | -109.63M | -163.28M | -163.63M | -182.38M | -227.86M | -234.5M | -303.28M | -305.2M | -294.76M | -301.12M | -255.33M | -232.06M | -205.75M | -168.67M | -150.15M | -143.6M |
EBIT | 41.18M | 12.08M | -2.89M | -28.67M | -74.11M | -106.45M | -112.22M | -165.81M | -165.11M | -183.9M | -229.38M | -235.99M | -304.61M | -306.38M | -295.81M | -302.03M | -256.2M | -232.8M | -206.36M | -169.09M | -150.42M | -143.82M |
Depreciation & Amortization | 2.95M | 2.95M | 5.52M | 4.72M | 5.59M | 5.37M | 2.6M | 2.53M | 1.48M | 1.6M | 1.61M | 1.57M | 1.42M | 1.18M | 1.05M | 910K | 866K | 736K | 605K | 429K | 267K | 220K |
Add to Watchlist
Select watchlists to add or remove ARQT